Literature DB >> 11850122

Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells.

William J Murdoch1, Edward A Van Kirk.   

Abstract

Ovarian surface epithelial cells have been implicated in the genesis of common ovarian cancers. The integrity of DNA of ovarian surface epithelial cells contiguous with the ovulatory stigma becomes compromised during the rupture process; most cells degenerate by apoptosis, however some, bearing sublethal lesions, persist along the margins of ovulated follicles. Clonal expansion of a genetically-damaged surface epithelial cell (i.e. with unrepaired DNA, but not committed to death) can presumably give rise to ovarian carcinoma. It was hypothesized that estradiol and progesterone regulate ovarian surface epithelial cell-cycle dynamics associated with folliculo-luteal transitions and ovulatory wound repair/remodeling. Progesterone up-regulated the tumor suppressor p53 and inhibited baseline and estradiol-stimulated proliferation of cultured sheep ovarian surface epithelial cells. Anti/mitotic responses to steroid hormones were transcriptionally- and receptor-dependent. Rates of apoptosis (DNA fragmentation) were unaffected by progesterone. High concentrations of estradiol, via a nongenomic (perhaps antioxidant) mechanism, suppressed basal and H(2)O(2)-induced apoptosis. We suggest that, progesterone serves to inhibit proliferation of ovarian surface epithelial cells throughout the luteal phase--providing the time (growth arrest) required to correct any metabolic disturbances to DNA that are perpetrated as an inevitable by-product of the ovulatory process. With luteolysis and dominance of an estrogenic preovulatory follicle the ovarian surface epithelium is then regenerated. Thus, it is conceivable that perturbations to the steroid hormonal milieu of ovarian cycles could be a predisposing factor for cancerous transformation of an ovarian surface epithelial cell.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850122     DOI: 10.1016/s0303-7207(01)00675-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

1.  Ovarian surface epithelium receptors during pregnancy and estrus cycle of rats with emphasis on steroids and gonadotropin fluctuation.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2014-03-13       Impact factor: 4.219

2.  Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

Authors:  Patricia G Moorman; Brian Calingaert; Rachel T Palmieri; Edwin S Iversen; Rex C Bentley; Susan Halabi; Andrew Berchuck; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2008-02-25       Impact factor: 4.897

Review 3.  Discovery of prognostic factors for diagnosis and treatment of epithelial-derived ovarian cancer from laying hens.

Authors:  Whasun Lim; Gwonhwa Song
Journal:  J Cancer Prev       Date:  2013-09

4.  Proliferation of the superficial epithelium of ovaries in senile female rats following oral administration of conjugated equine estrogens.

Authors:  Sergio Eduardo Perniconi; Manuel de Jesus Simões; Ricardo Dos Santos Simões; Mauro Abi Haidar; Edmund C Baracat; Jose Maria Soares
Journal:  Clinics (Sao Paulo)       Date:  2008-06       Impact factor: 2.365

5.  E-cadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 mice.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Clare R Beaugié; Vicki Livingstone
Journal:  Reprod Biol Endocrinol       Date:  2007-04-11       Impact factor: 5.211

Review 6.  Animal models of ovarian cancer.

Authors:  Barbara C Vanderhyden; Tanya J Shaw; Jean-François Ethier
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

7.  17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo.

Authors:  Laura A Laviolette; Kendra M Hodgkinson; Neha Minhas; Carol Perez-Iratxeta; Barbara C Vanderhyden
Journal:  Int J Cancer       Date:  2014-02-25       Impact factor: 7.396

Review 8.  The Chemoprevention of Ovarian Cancer: the Need and the Options.

Authors:  Rishil J Kathawala; Andrzej Kudelka; Basil Rigas
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

9.  Cell type-specific genotoxicity in estrogen-exposed ovarian and fallopian epithelium.

Authors:  Liang Song; Zizhi Tang; Changsheng Peng; Yueming Yang; Chang Guo; Danqing Wang; Liandi Guo; Jie Chen; Cong Liu
Journal:  BMC Cancer       Date:  2020-10-21       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.